Your browser doesn't support javascript.
loading
Resolving Behavioral Output via Chemogenetic Designer Receptors Exclusively Activated by Designer Drugs.
Burnett, C Joseph; Krashes, Michael J.
Afiliación
  • Burnett CJ; Diabetes, Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, and Brown University-National Institutes of Health Graduate Partnerships Program, Providence, Rhode Island 02912.
  • Krashes MJ; Diabetes, Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, and michael.krashes@nih.gov.
J Neurosci ; 36(36): 9268-82, 2016 09 07.
Article en En | MEDLINE | ID: mdl-27605603

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Conducta / Drogas de Diseño / Diseño de Fármacos / Transducción de Señal / Receptores Acoplados a Proteínas G Límite: Animals / Humans Idioma: En Revista: J Neurosci Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Conducta / Drogas de Diseño / Diseño de Fármacos / Transducción de Señal / Receptores Acoplados a Proteínas G Límite: Animals / Humans Idioma: En Revista: J Neurosci Año: 2016 Tipo del documento: Article